AstraZeneca PLC (AZN) is trading at $168.90 down 0.23% over the past 24 hours. Its Galaxy Score is 65.8, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 2.4M engagements and 334 posts with 15% positive social sentiment.
AI summary: AstraZeneca's EGFR program, boosted by a licensing deal with Dizal for sunvozertinib, faces ongoing governance and regulatory headwinds that limit upside despite near-term catalysts. Price action is muted at $168.90 as governance and regulatory headwinds cap upside, despite the Dizal deal signaling EGFR momentum; investors await regulatory relief and market access.
AstraZeneca PLC (AZN) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
AstraZeneca PLC (AZN) is trading at $168.90, down 0.23% over the past 24 hours.
$AZN has a Galaxy Score of 65.8 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Not right now. $AZN social sentiment is 15% positive across social posts over the last 24 hours.
There have been 334 posts about $AZN over the last 24 hours.
On LunarCrush — follow $AZN's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.